BACK

How do COVID-19 vaccine antibodies differ from ones produced from a natural infection?

How do COVID-19 vaccine antibodies differ from ones produced from a natural infection?

This article was published on
April 22, 2021

This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.

This article has been translated from its original language. Please reach out if you have any feedback on the translation.

The COVID-19 antibodies that your body develops from getting vaccinated are mostly the same kind of antibodies you develop from an infection.

The COVID-19 antibodies that your body develops from getting vaccinated are mostly the same kind of antibodies you develop from an infection.

Publication

What our experts say

COVID-19 vaccines help people build up protection to the virus without having to get sick and risk illness or death. We still need more time and evidence to know how long immunity will last following a COVID-19 vaccination.

Similarly, if you are exposed to the COVID-19 virus (not the vaccine) and build up natural immunity, the next time you're exposed your antibodies will likely disarm the virus so you don't get infected or have symptoms. In less common cases, you would at least be protected from a more severe case of COVID-19.

We don’t yet know exactly how protective “natural” antibodies are, and for how long. The British Society of Immunology states that the immunity acquired from a COVID-19 infection is variable, and its duration is unknown, adding that it might be lower in people who had a mild COVID-19 infection. We do know that there have been very few cases of COVID-19 reinfection, and that immunity acquired from one variant of COVID-19 is not guaranteed to protect against a different variant.

A key scientific difference between these two scenarios—immunity through vaccines vs. immunity from getting infected — are the parts of the virus that are helping to build that immunity. When designing a vaccine, researchers carefully expose individuals to a part or parts of the virus that help us produce immunity-boosting antibodies. Natural COVID-19 infection exposes people to the whole virus—not a carefully selected set of its traits.

Importantly, it’s not feasible to compare immunity from vaccination to immunity from infection accurately. Different vaccines have different ingredients and mechanisms, and trigger different immune responses in different people. In some cases, a vaccine might not provide as strong of an antibody response as the virus itself. Other times, it may be the vaccines that trigger the stronger antibodies. Antibodies aren't the only measure for immunity against viruses, either.

Current evidence now suggests that both vaccinated and unvaccinated individuals can be carriers of COVID-19, posing a threat to their communities. A study conducted in Kentucky, United States, between May and June of 2021 examined people who had previous COVID-19 infection in 2020, and compared the number of repeated infections among those who were later vaccinated, and those who were not. The study found that the group who was not vaccinated after having had a previous infection had more than double the likelihood of getting reinfected by COVID-19. Because of this study, CDC Director Rochelle Walensky urges every eligible person to get vaccinated even if they had previously gotten a COVID-19 infection.  Combined with the threat of reinfection and breakthrough infections by the Delta variant, the United States’ Center for Disease Control and Prevention has re-issued the mask mandate for public indoor spaces, regardless of vaccine status. It is advisable to maintain social-distancing, avoid crowded areas, hand washing and to continue using masks indoors in order to help end this pandemic and protect yourself, and your close contacts. 

COVID-19 vaccines help people build up protection to the virus without having to get sick and risk illness or death. We still need more time and evidence to know how long immunity will last following a COVID-19 vaccination.

Similarly, if you are exposed to the COVID-19 virus (not the vaccine) and build up natural immunity, the next time you're exposed your antibodies will likely disarm the virus so you don't get infected or have symptoms. In less common cases, you would at least be protected from a more severe case of COVID-19.

We don’t yet know exactly how protective “natural” antibodies are, and for how long. The British Society of Immunology states that the immunity acquired from a COVID-19 infection is variable, and its duration is unknown, adding that it might be lower in people who had a mild COVID-19 infection. We do know that there have been very few cases of COVID-19 reinfection, and that immunity acquired from one variant of COVID-19 is not guaranteed to protect against a different variant.

A key scientific difference between these two scenarios—immunity through vaccines vs. immunity from getting infected — are the parts of the virus that are helping to build that immunity. When designing a vaccine, researchers carefully expose individuals to a part or parts of the virus that help us produce immunity-boosting antibodies. Natural COVID-19 infection exposes people to the whole virus—not a carefully selected set of its traits.

Importantly, it’s not feasible to compare immunity from vaccination to immunity from infection accurately. Different vaccines have different ingredients and mechanisms, and trigger different immune responses in different people. In some cases, a vaccine might not provide as strong of an antibody response as the virus itself. Other times, it may be the vaccines that trigger the stronger antibodies. Antibodies aren't the only measure for immunity against viruses, either.

Current evidence now suggests that both vaccinated and unvaccinated individuals can be carriers of COVID-19, posing a threat to their communities. A study conducted in Kentucky, United States, between May and June of 2021 examined people who had previous COVID-19 infection in 2020, and compared the number of repeated infections among those who were later vaccinated, and those who were not. The study found that the group who was not vaccinated after having had a previous infection had more than double the likelihood of getting reinfected by COVID-19. Because of this study, CDC Director Rochelle Walensky urges every eligible person to get vaccinated even if they had previously gotten a COVID-19 infection.  Combined with the threat of reinfection and breakthrough infections by the Delta variant, the United States’ Center for Disease Control and Prevention has re-issued the mask mandate for public indoor spaces, regardless of vaccine status. It is advisable to maintain social-distancing, avoid crowded areas, hand washing and to continue using masks indoors in order to help end this pandemic and protect yourself, and your close contacts. 

Context and background

Antibodies are crucial for fighting certain types of infections, including COVID-19. Through a range of mechanisms, and in coordination with different parts of the immune system, some antibodies can completely disarm a virus.

Information has circulated online that getting infected with COVID-19 produces a better antibody response than the vaccine. Whether an antibody response following a vaccine is stronger than one following infection depends on a range of factors, and can go both ways. 

Additionally, though vaccines can protect individuals from getting COVID-19, comparing the two types of immunity can be difficult because the purpose of vaccine development for COVID-19 is to prevent severe illness and death, not the infection itself.

New evidence from researchers in Israel suggests that getting vaccinated after a COVID-19 infection provides more protection than the vaccine, or the infection, by themselves. The study also concluded that people who vaccinated without prior COVID-19 infection were more likely to get infected than those who had natural immunity from a previous infection. However, the study did not capture asymptomatic cases, as these recover on their own without testing and are not detectable through medical records. More research is currently needed to confirm this finding.

Antibodies are crucial for fighting certain types of infections, including COVID-19. Through a range of mechanisms, and in coordination with different parts of the immune system, some antibodies can completely disarm a virus.

Information has circulated online that getting infected with COVID-19 produces a better antibody response than the vaccine. Whether an antibody response following a vaccine is stronger than one following infection depends on a range of factors, and can go both ways. 

Additionally, though vaccines can protect individuals from getting COVID-19, comparing the two types of immunity can be difficult because the purpose of vaccine development for COVID-19 is to prevent severe illness and death, not the infection itself.

New evidence from researchers in Israel suggests that getting vaccinated after a COVID-19 infection provides more protection than the vaccine, or the infection, by themselves. The study also concluded that people who vaccinated without prior COVID-19 infection were more likely to get infected than those who had natural immunity from a previous infection. However, the study did not capture asymptomatic cases, as these recover on their own without testing and are not detectable through medical records. More research is currently needed to confirm this finding.

Resources

  1. Antibodies From Vaccines vs. Antibodies From Natural Infection (Very Well Health)
  2. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. (Infection and Immunity)
  3. Antibodies, immunity, and COVID-19 (JAMA Internal Medicine)
  4. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? (Vaccine X)
  5. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients (Science Immunology)
  6. How long does immunity last after COVID-19 vaccination? (Gavi: The Vaccine Alliance)
  7. ‘Natural Immunity’ From Covid Is Not Safer Than a Vaccine (The New York Times)
  1. Antibodies From Vaccines vs. Antibodies From Natural Infection (Very Well Health)
  2. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. (Infection and Immunity)
  3. Antibodies, immunity, and COVID-19 (JAMA Internal Medicine)
  4. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2? (Vaccine X)
  5. Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients (Science Immunology)
  6. How long does immunity last after COVID-19 vaccination? (Gavi: The Vaccine Alliance)
  7. ‘Natural Immunity’ From Covid Is Not Safer Than a Vaccine (The New York Times)

Media briefing

Media Release

Expert Comments: 

No items found.

Q&A

No items found.